“Now we have chemotherapy-free immunotherapy options for patients whose myeloma has relapsed for the first time,” said senior ...

The bispecific antibody therapy works by activating the body’s immune system to attack cancer cells, binding simultaneously ...

New BCMA-targeted bispecific antibody addresses critical unmet need in India, offering deep and durable responses for heavily ...

LB2102 demonstrated a manageable safety profile and encouraging clinical activity in solid tumors among heavily pretreated patients Responses observed at higher dose levels of LB2102 with an ORR of 28 ...

Today we revisit the American Society of Clinical Oncology scientific meeting in Chicago, which concluded on Tuesday, to report on three more potentially practice-changing studies.

My husband is very upset and feels that a death sentence is hanging over him.

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

Buy Legend Biotech (LEGN): new Carvykti CARTITUDE-4 data show better survival and <1% Parkinsonism; upside at 3.0x ...

Initial findings show that the therapy reduced or eliminated disease signs in all recipients, sparking hopes that the ...